HUT51612A - Process for producing quinolinone derivatives and pharmaceutical preparations containing these derivatives as active agents - Google Patents
Process for producing quinolinone derivatives and pharmaceutical preparations containing these derivatives as active agentsInfo
- Publication number
- HUT51612A HUT51612A HU895268A HU526889A HUT51612A HU T51612 A HUT51612 A HU T51612A HU 895268 A HU895268 A HU 895268A HU 526889 A HU526889 A HU 526889A HU T51612 A HUT51612 A HU T51612A
- Authority
- HU
- Hungary
- Prior art keywords
- derivatives
- producing
- active agents
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8813324A FR2637591B1 (fr) | 1988-10-11 | 1988-10-11 | Derives de quinoleinone, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU895268D0 HU895268D0 (en) | 1990-01-28 |
| HUT51612A true HUT51612A (en) | 1990-05-28 |
| HU204813B HU204813B (en) | 1992-02-28 |
Family
ID=9370884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU895268A HU204813B (en) | 1988-10-11 | 1989-10-10 | Process for producing quinoline derivatives and pharmaceutical compositions comprising such derivatives as active ingredient |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4983607A (hu) |
| EP (1) | EP0364327B1 (hu) |
| JP (1) | JPH02157267A (hu) |
| KR (1) | KR900006317A (hu) |
| AT (1) | ATE71617T1 (hu) |
| AU (1) | AU619349B2 (hu) |
| CS (1) | CS404891A3 (hu) |
| DE (1) | DE68900717D1 (hu) |
| DK (1) | DK500189A (hu) |
| ES (1) | ES2037980T3 (hu) |
| FI (1) | FI91748C (hu) |
| FR (1) | FR2637591B1 (hu) |
| GR (1) | GR3003921T3 (hu) |
| HU (1) | HU204813B (hu) |
| IE (1) | IE61830B1 (hu) |
| IL (1) | IL91930A (hu) |
| NO (1) | NO173058C (hu) |
| NZ (1) | NZ230959A (hu) |
| PT (1) | PT91939B (hu) |
| ZA (1) | ZA897672B (hu) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2635105B1 (fr) * | 1988-08-03 | 1991-01-25 | Synthelabo | Derives de piperazine et leur procede de preparation |
| US5457099A (en) * | 1992-07-02 | 1995-10-10 | Sawai Pharmaceutical Co., Ltd. | Carbostyril derivatives and antiallergic agent |
| DK148392D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocykliske forbindelser |
| WO1994020471A1 (en) * | 1993-03-05 | 1994-09-15 | Merck Sharp & Dohme Limited | Quinolone derivatives as dopamine d4 ligands |
| WO1994021619A1 (en) * | 1993-03-16 | 1994-09-29 | Pfizer Inc. | Naphthalene derivatives |
| FR2737723B1 (fr) * | 1995-08-09 | 1997-09-05 | Synthelabo | Derives de 1-(2-(1h-inden-3-yl)ethyl)-4-(naphtalen-1-yl)- piperazine, leur preparation et leur application en therapeutique |
| FR2738823B1 (fr) * | 1995-09-15 | 1997-10-31 | Synthelabo | Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique |
| FR2761071B1 (fr) * | 1997-03-20 | 1999-12-03 | Synthelabo | Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique |
| FR2761067B1 (fr) * | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique |
| US6562837B1 (en) * | 1998-10-21 | 2003-05-13 | Korea Institute Of Science & Technology | Use of tetrahydroisoquinoline compounds for the treatment of septicemia |
| NZ535616A (en) | 2000-11-07 | 2006-03-31 | Novartis Ag | Indolymaleimide derivatives as protein kinase c inhibitors |
| US7053092B2 (en) * | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
| US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| TW200803855A (en) * | 2006-02-24 | 2008-01-16 | Kalypsys Inc | Quinolones useful as inducible nitric oxide synthase inhibitors |
| NZ590041A (en) * | 2008-05-20 | 2012-11-30 | Astrazeneca Ab | Method of treating anxious major depressive disorder |
| MA41168A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54128588A (en) * | 1978-03-29 | 1979-10-05 | Dainippon Pharmaceut Co Ltd | Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline |
| JPS54130587A (en) * | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
| US4284768A (en) * | 1980-07-02 | 1981-08-18 | American Home Products Corporation | 1,2-Dihydro-4-amino-2-oxo-3-quinoline-carboxylic acid derivatives |
| GB8827189D0 (en) * | 1988-11-21 | 1988-12-29 | Fujisawa Pharmaceutical Co | 2(1h)-quinolinone compounds processes for preparation thereof & pharmaceutical composition comprising same |
-
1988
- 1988-10-11 FR FR8813324A patent/FR2637591B1/fr not_active Expired - Fee Related
-
1989
- 1989-10-02 ES ES198989402700T patent/ES2037980T3/es not_active Expired - Lifetime
- 1989-10-02 EP EP89402700A patent/EP0364327B1/fr not_active Expired - Lifetime
- 1989-10-02 DE DE8989402700T patent/DE68900717D1/de not_active Expired - Lifetime
- 1989-10-02 AT AT89402700T patent/ATE71617T1/de not_active IP Right Cessation
- 1989-10-09 ZA ZA897672A patent/ZA897672B/xx unknown
- 1989-10-10 NO NO894036A patent/NO173058C/no not_active IP Right Cessation
- 1989-10-10 US US07/417,970 patent/US4983607A/en not_active Expired - Lifetime
- 1989-10-10 NZ NZ230959A patent/NZ230959A/en unknown
- 1989-10-10 HU HU895268A patent/HU204813B/hu not_active IP Right Cessation
- 1989-10-10 IE IE326589A patent/IE61830B1/en not_active IP Right Cessation
- 1989-10-10 KR KR1019890014520A patent/KR900006317A/ko not_active Application Discontinuation
- 1989-10-10 FI FI894803A patent/FI91748C/fi not_active IP Right Cessation
- 1989-10-10 PT PT91939A patent/PT91939B/pt not_active IP Right Cessation
- 1989-10-10 DK DK500189A patent/DK500189A/da not_active Application Discontinuation
- 1989-10-10 AU AU42750/89A patent/AU619349B2/en not_active Ceased
- 1989-10-10 IL IL91930A patent/IL91930A/xx not_active IP Right Cessation
- 1989-10-11 JP JP1266051A patent/JPH02157267A/ja active Pending
-
1991
- 1991-12-23 CS CS914048A patent/CS404891A3/cs unknown
-
1992
- 1992-02-27 GR GR920400344T patent/GR3003921T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ230959A (en) | 1990-12-21 |
| HU204813B (en) | 1992-02-28 |
| IL91930A (en) | 1993-08-18 |
| DK500189A (da) | 1990-04-12 |
| DE68900717D1 (de) | 1992-02-27 |
| GR3003921T3 (hu) | 1993-03-16 |
| IL91930A0 (en) | 1990-06-10 |
| IE61830B1 (en) | 1994-11-30 |
| FI91748B (fi) | 1994-04-29 |
| US4983607A (en) | 1991-01-08 |
| EP0364327A1 (fr) | 1990-04-18 |
| ZA897672B (en) | 1990-07-25 |
| NO173058B (no) | 1993-07-12 |
| AU4275089A (en) | 1990-04-26 |
| NO894036D0 (no) | 1989-10-10 |
| FR2637591B1 (fr) | 1992-10-23 |
| PT91939A (pt) | 1990-04-30 |
| KR900006317A (ko) | 1990-05-07 |
| ATE71617T1 (de) | 1992-02-15 |
| AU619349B2 (en) | 1992-01-23 |
| IE893265L (en) | 1990-04-11 |
| NO173058C (no) | 1993-10-20 |
| FI91748C (fi) | 1994-08-10 |
| ES2037980T3 (es) | 1993-07-01 |
| JPH02157267A (ja) | 1990-06-18 |
| FR2637591A1 (fr) | 1990-04-13 |
| EP0364327B1 (fr) | 1992-01-15 |
| CS404891A3 (en) | 1992-04-15 |
| FI894803A (fi) | 1990-04-12 |
| NO894036L (no) | 1990-04-17 |
| PT91939B (pt) | 1995-05-31 |
| DK500189D0 (da) | 1989-10-10 |
| HU895268D0 (en) | 1990-01-28 |
| FI894803A0 (fi) | 1989-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT51612A (en) | Process for producing quinolinone derivatives and pharmaceutical preparations containing these derivatives as active agents | |
| DE3365772D1 (en) | 1,4-dihydropyridines, process for their preparation and their application as pharmaceutical preparations | |
| NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| NO883994D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer. | |
| ATE22891T1 (de) | Pyrimidinonderivate und diese enthaltende pharmazeutische zusammensetzungen. | |
| MD382C2 (ro) | Procedeu de obţinere a piperazinilalchil-3(2H)-piridazinonelor sau a sărurilor lor farmaceutice admisibile | |
| GR920100570A (el) | Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους. | |
| DK160686A (da) | Tri- og tetracycliske forbindelser | |
| FR2618436B1 (fr) | Derives de piperidine, leur preparation et leur application en therapeutique | |
| NO840526L (no) | Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter | |
| DK627584A (da) | Benzothiazinderivater og fysiologisk acceptable salte deraf, fremgangsmaade og mellemprodukt til deres fremstilling samt deres anvendelse | |
| NO172541C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater | |
| ES2065192T3 (es) | Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| HUT44500A (en) | Process for producing methionin-substituted new 1,4-dihydro-pyridine derivatives and pharmaceutical compositions containing them | |
| CA2049440A1 (en) | Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |